Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5921)
All Articles published online
|
Publishing Process of This Article
|
Oct 27, 2020 (publication date) through Dec 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lisboa QC, Nardelli MJ, Pereira PA, Miranda DM, Ribeiro SN, Costa RSN, Versiani CA, Vidigal PVT, Ferrari TCA, Couto CA. PNPLA3 and TM6SF2 polymorphisms in Brazilian patients with nonalcoholic fatty liver disease. World J Hepatol 2020; 12(10): 792-806 [PMID: 33200017 DOI: 10.4254/wjh.v12.i10.792] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v12/i10/792.htm |
| Number | Citing Articles |
| 1 |
O. V. Smirnova, D. V. Lagutinskaya. The role of polymorphisms of <I>PNPLA3</I>, <I>MBOAT7</I>, and <I>TM6SF2</I> in the development of non-alcoholic fatty liver disease in metabolic syndrome. Obesity and metabolism 2022; 19(2): 166 doi: 10.14341/omet12855
|
| 2 |
Siti Aishah Sulaiman, Vicneswarry Dorairaj, Muhammad Nafiz Haidi Adrus. Genetic Polymorphisms and Diversity in Nonalcoholic Fatty Liver Disease (NAFLD): A Mini Review. Biomedicines 2022; 11(1): 106 doi: 10.3390/biomedicines11010106
|
| 3 |
Natália Coelho Lavrado, Gil Fernando Salles, Claudia Regina Lopes Cardoso, Paulo Henrique Condeixa de França, Maria Fernanda Di Guimarães Gonçalves Melo, Nathalie Carvalho Leite, Cristiane Alves Villela‐Nogueira. Impact of PNPLA3 and TM6SF2 polymorphisms on the prognosis of patients with MASLD and type 2 diabetes mellitus. Liver International 2024; 44(4): 1042 doi: 10.1111/liv.15845
|
| 4 |
Pablo Gabriel-Medina, Roser Ferrer-Costa, Francisco Rodriguez-Frias, Andreea Ciudin, Salvador Augustin, Jesus Rivera-Esteban, Juan M. Pericàs, David Martinez Selva. Influence of Type 2 Diabetes in the Association of PNPLA3 rs738409 and TM6SF2 rs58542926 Polymorphisms in NASH Advanced Liver Fibrosis. Biomedicines 2022; 10(5): 1015 doi: 10.3390/biomedicines10051015
|
| 5 |
Mauy Frujuello Mana, Maria Cândida R. Parisi, Maria Lucia Correa-Giannella, Arnaldo Moura Neto, Ademar Yamanaka, Marlone Cunha-Silva, Ana Mercedes Cavaleiro, Cristina Rodrigues dos Santos, Célia Regina Pavan, Tiago Sevá-Pereira, Sergio S. J. Dertkigil, Daniel F. Mazo. Non-Alcoholic Fatty Liver Disease in Long-Term Type 2 Diabetes: Role of rs738409 PNPLA3 and rs499765 FGF21 Polymorphisms and Serum Biomarkers. Molecules 2022; 27(10): 3193 doi: 10.3390/molecules27103193
|
| 6 |
Lourianne Nascimento Cavalcante, Jun Porto, Daniel Mazo, Adhemar Longatto-Filho, José Tadeu Stefano, Andre Castro Lyra, Flair Jose Carrilho, Rui Manuel Reis, Venâncio A.F. Alves, Arun J. Sanyal, Claudia P Oliveira. African genetic ancestry is associated with lower frequency of PNPLA3 G allele in non-alcoholic fatty liver in an admixed population. Annals of Hepatology 2022; 27(6): 100728 doi: 10.1016/j.aohep.2022.100728
|
| 7 |
Saeideh Maleki, Heidar Sharafi, Behnam Honarvar, Maryam Eslami, Kamran Bagheri Lankarani, Seyed Moayed Alavian. Association of PNPLA3 rs738409 and TM6SF2 rs58542926 Polymorphisms with Non-alcoholic Fatty Liver Disease in the Iranian Population. Hepatitis Monthly 2022; 22(1) doi: 10.5812/hepatmon-133330
|
| 8 |
Weili Chen, Lingling Cao, Zhaoping Wu. Association Between Physical Activity and Prevalence/Mortality of Non-Alcoholic Fatty Liver Disease in Different Socioeconomic Settings. International Journal of Public Health 2023; 68 doi: 10.3389/ijph.2023.1605031
|
| 9 |
Ming Ren Toh, Evelyn Yi Ting Wong, Sunny Hei Wong, Alvin Wei Tian Ng, Lit-Hsin Loo, Pierce Kah-Hoe Chow, Joanne Ngeow. Global Epidemiology and Genetics of Hepatocellular Carcinoma. Gastroenterology 2023; 164(5): 766 doi: 10.1053/j.gastro.2023.01.033
|
| 10 |
Mykhailo Buchynskyi, Valentyn Oksenych, Iryna Kamyshna, Sandor G. Vari, Aleksandr Kamyshnyi. Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive Analysis. Viruses 2023; 15(8): 1724 doi: 10.3390/v15081724
|
| 11 |
Ehsan Amini-Salehi, Negin Letafatkar, Naeim Norouzi, Farahnaz Joukar, Arman Habibi, Mona Javid, Nazila Sattari, Mehrdad Khorasani, Ali Farahmand, Shervin Tavakoli, Behnaz Masoumzadeh, Elaheh Abbaspour, Sahand Karimzad, Amir Ghadiri, Gautam Maddineni, Mohammad Javad Khosousi, Niloofar Faraji, Mohammad-Hossein Keivanlou, Abinash Mahapatro, Mohamad Amin Khajavi Gaskarei, Paria Okhovat, Ali Bahrampourian, Maryam Sadat Aleali, Arian Mirdamadi, Narges Eslami, Mohamadreza Javid, Naz Javaheri, Shrinidhi Vilas Pra, Arash Bakhsi, Mohammad Shafipour, Azin Vakilpour, Malek Moein Ansar, Sai Guatham Kanagala, Mohamad Hashemi, Arezoo Ghazalgoo, Masoumeh Kheirandish, Parham Porteghali, Forough Heidarzad, Taraneh Zeinali, Fariborz Mansour Ghanaei, Soheil Hassanipour, Michael.T Ulrich, Joshua E. Melson, Dhruvan Patel, Sandeep Samethadka Nayak. Global Prevalence of Nonalcoholic Fatty Liver Disease: An Updated Review Meta-Analysis comprising a Population of 78 million from 38 Countries. Archives of Medical Research 2024; 55(6): 103043 doi: 10.1016/j.arcmed.2024.103043
|
| 12 |
Luis Antonio Díaz, Marcela Villota-Rivas, Francisco Barrera, Jeffrey V. Lazarus, Marco Arrese. The burden of liver disease in Latin America. Annals of Hepatology 2024; 29(3): 101175 doi: 10.1016/j.aohep.2023.101175
|
| 13 |
Fajar Dwi Astarini, Neneng Ratnasari, Widya Wasityastuti. Update on Non-Alcoholic Fatty Liver Disease-Associated Single Nucleotide Polymorphisms and Their Involvement in Liver Steatosis, Inflammation, and Fibrosis: A Narrative Review. Iranian Biomedical Journal 2022; 26(4): 252 doi: 10.52547/ibj.3647
|
| 14 |
Limin Cao, Yu An, Huiyuan Liu, Jinguo Jiang, Wenqi Liu, Yuhan Zhou, Mengyuan Shi, Wei Dai, Yanling Lv, Yuhong Zhao, Yanhui Lu, Liangkai Chen, Yang Xia. Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis. BMC Medicine 2024; 22(1) doi: 10.1186/s12916-024-03315-0
|
| 15 |
Ainura Amirkulova, Gulmira Derbissalina, Valeriy Benberin, Nasrulla Shanazarov, Gulshara Abildinova, Doskhan Kozhakhmet, Helena Katchman. Association between PNPLA3 and TM6SF2 gene polymorphisms and non-alcoholic fatty liver disease patients in Kazakhstan. Electronic Journal of General Medicine 2023; 20(6): em546 doi: 10.29333/ejgm/13718
|
| 16 |
Siarhei A. Dabravolski, Evgeny E. Bezsonov, Mirza S. Baig, Tatyana V. Popkova, Ludmila V. Nedosugova, Antonina V. Starodubova, Alexander N. Orekhov. Mitochondrial Mutations and Genetic Factors Determining NAFLD Risk. International Journal of Molecular Sciences 2021; 22(9): 4459 doi: 10.3390/ijms22094459
|
| 17 |
Maryam Khalilinejad, Mandana Gholami, Fereshteh Shahmohammadi Dermani, Farshad Ghazalian. The Effect of Four Weeks of Swimming Training on Insulin Resistance and Hepatokines in Rats with PCOS. Journal of Health Reports and Technology 2024; 10(1) doi: 10.5812/jhrt-140930
|
| 18 |
Madhangi Parameswaran, Hamzah A Hasan, Jafor Sadeque, Sharan Jhaveri, Chaithanya Avanthika, Abimbola E Arisoyin, Maulik B Dhanani, Swaroopa M Rath . Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD). Cureus 2021; doi: 10.7759/cureus.20776
|
| 19 |
Arthur Ivan N. Oliveira, Fernanda M. Malta, Patricia Momoyo Y. Zitelli, Ana Paula M. Salles, Michele S. Gomes-Gouvea, Ana Catharina S. Nastri, Joao Renato R. Pinho, Flair J. Carrilho, Claudia P. Oliveira, Maria Cássia Mendes-Corrêa, Mario G. Pessoa, Daniel F. Mazo. The role of PNPLA3 and TM6SF2 polymorphisms on liver fibrosis and metabolic abnormalities in Brazilian patients with chronic hepatitis C. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01654-3
|
| 20 |
Satender P. Singh, Tushar Madke, Phool Chand. Global Epidemiology of Hepatocellular Carcinoma. Journal of Clinical and Experimental Hepatology 2025; 15(2): 102446 doi: 10.1016/j.jceh.2024.102446
|
| 21 |
Chunye Zhang, Ming Yang. Current Options and Future Directions for NAFLD and NASH Treatment. International Journal of Molecular Sciences 2021; 22(14): 7571 doi: 10.3390/ijms22147571
|
| 22 |
Yan Zhao, Wenli Zhao, Jingchao Ma, Maeda Toshiyoshi, Ye Zhao. Patatin-like phospholipase domain-containing 3 gene (PNPLA3) polymorphic (rs738409) single nucleotide polymorphisms and susceptibility to nonalcoholic fatty liver disease: A meta-analysis of twenty studies. Medicine 2023; 102(10): e33110 doi: 10.1097/MD.0000000000033110
|
| 23 |
Xue-Ying Li, Zheng Liu, Li Li, Hai-Jun Wang, Hui Wang. TM6SF2 rs58542926 is related to hepatic steatosis, fibrosis and serum lipids both in adults and children: A meta-analysis. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.1026901
|